Xylem (XYL) Could Be 30% Undervalued As Its Growth Story Gets Tested
Xylem (XYL) has drawn attention after its recent share performance, with the stock down about 10% over the past month, even as its 3 year total return remains positive.
The recent 1 day share price return of 2.95% to US$108.81 comes after a tougher spell, with the 30 day share price return down 9.57% and the year to date share price return down 20.64%. However, the 3 year total shareholder return of 16.92% suggests Xylem has still rewarded longer term holders even as momentum has faded in the past year.
Compare Xylem's recent pullback with other potential opportunities by scanning our curated 49 high quality undervalued stocks, which pairs solid fundamentals with compressed share prices.
Xylem’s slide over the past year could point to concern about the business, or it could simply reflect cooling enthusiasm after a strong multiyear stretch. Does the current share price fairly reflect what investors receive?
Most Popular Narrative: 29.8% Undervalued
Against Xylem’s last close at $108.81, the most followed narrative anchors fair value at $155 per share, implying a sizable valuation gap that rests on specific performance milestones being met.
Investment thesis: Xylem is a water-infrastructure company that participates in municipal, industrial, commercial and residential water spending. Long-term demand is associated with ageing water infrastructure, water scarcity, water-treatment requirements, digital monitoring and data-centre water demand. The thesis centers on converting these structural trends into steady growth, margin improvement, free cash flow generation and disciplined acquisitions.
Want to see how this thesis supports a triple digit fair value for Xylem? The core narrative focuses on steady top line expansion, faster earnings compounding and disciplined capital deployment. It examines which specific growth, margin and cash conversion assumptions would need to hold for that price to be reasonable. The full breakdown details each step in that calculation.
Result: Fair Value of $155 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, the Xylem narrative can unravel quickly if revenue growth slows below expectations or if recent pump acquisitions fail to deliver acceptable returns.
Find out about the key risks to this Xylem narrative.
Next Steps
If the Xylem story so far feels mixed, take that as a prompt to move quickly and stress test the numbers yourself. Then round out your view by reviewing the 6 key rewards
Looking for more ideas beyond Xylem?
Once you have sized up Xylem, do not stop there. Broader context matters, and fresh ideas often come from scanning outside your usual comfort zone.
- Target resilient income by reviewing 6 dividend fortresses that aim to combine higher yields with balance sheet strength.
- Spot mispriced potential by scanning our 17 high quality undiscovered gems before the wider market catches on.
- Protect the downside by focusing on 83 resilient stocks with low risk scores that score well on financial robustness and volatility.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com